J.P.Morgan Software Investment Banking
Strategics buyer insights - Dassault Systems / Medidata
JPMorgan
relationship
Strategic
rationale
Notable
M&A deals
#medidata
Jun '19
$5.8bn
Life Sciences lifecycle
management
Bernard Charles
CEO
J.P.Morgan
Company filings: press releases: FactSet as of 4/29/21
Note: All transaction multiples reflect NTM, unless noted otherwise
Extend Dassault's life sciences business as its core competency to become its largest business segment in the company
• Immediately access Inovalon's massive primary-source datasets to enhance Dassault / Medidata's cloud-based data & analytics capabilities
• Enable Dassault's expansion into other key segments of healthcare, including payers and providers
• Cross-sell opportunities and synergies with Inovalon platform
IQMS
Manufacturing ERP
Key decision makers
Dec '18
$425mm
Manufacturing ERP
software
Pascal Daloz
COO & CFO
Corporate Strategy Officer
Market cap: $63.3bn
FV / 22E Rev.: 10.4x
FV /'22E uFCF: 47.8x
Exa
Sep '17
$400mm
Product engineering
software
Tarek Shelif
CEO & Co-founder, Medidata
43View entire presentation